Nationwide Fund Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-173,157	Closed	-$26.3M	–	2055
2017 Q3	$26.3M	Buy	173,157 +56,646	+49%	+$8.53M	0.1%	215
2017 Q2	$15M	Sell	116,511 -5,407	-4%	-$651K	0.06%	450
2017 Q1	$13.3M	Sell	121,918 -99,438	-45%	-$8.75M	0.05%	510
2016 Q4	$16.3M	Sell	221,356 -40,925	-16%	-$3.33M	0.07%	386
2016 Q3	$22.9M	Buy	262,281 +154,249	+143%	+$14.6M	0.1%	240
2016 Q2	$9.29M	Buy	108,032 +8,421	+8%	+$728K	0.04%	609
2016 Q1	$7.92M	Sell	99,611 -33,234	-25%	-$3.01M	0.03%	695
2015 Q4	$16.7M	Sell	132,845 -145,545	-52%	-$17.6M	0.07%	353
2015 Q3	$29M	Sell	278,390 -9,280	-3%	-$1.19M	0.13%	166
2015 Q2	$35.5M	Buy	287,670 +2,031	+0.7%	+$256K	0.15%	141
2015 Q1	$33.7M	Sell	285,639 -39,078	-12%	-$4.68M	0.14%	159
2014 Q4	$38.6M	Buy	324,717 +20,724	+7%	+$2.33M	0.16%	129
2014 Q3	$34.1M	Sell	303,993 -26,123	-8%	-$2.49M	0.14%	151
2014 Q2	$31.3M	Buy	330,116 +65,841	+25%	+$4.62M	0.13%	186
2014 Q1	$18.7M	Sell	264,275 -5,854	-2%	-$464K	0.09%	289
2013 Q4	$20.1M	Sell	270,129 -23,687	-8%	-$1.65M	0.08%	286
2013 Q3	$22.3M	Sell	293,816 -189,679	-39%	-$15.1M	0.1%	237
2013 Q2	$38.6M	Buy	+483,495	New	+$35.6M	0.2%	84